Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
Authors
Jones, S E; Schottstaedt, M W; Duncan, L A; Kirby, R L; Good, R H; Mennel, R G; George, T K; Snyder, D A; Watkins, D L; Denham, C A; Hoyes, F A; Rubin, A S
Publication
Journal of Clinical Oncology, 1996, Vol 14, Issue 11, p2976